Background
Single Balloon Enteroscopy (SBE) is a novel deep enteroscopy modality for diagnosis and treatment of disorders of the small bowel.
Objective
The aim of the study was to examine the performance, yield and safety of SBE in the initial experience at a tertiary care center.
Design
Retrospective analysis of all SBEs during a 10 month period in 2008. Data was extracted from electronic clinical and endoscopy records.
Setting
U.S. tertiary care center.
Patients
All patients referred for SBE were included in the current analysis.
Intervention
SBE.
Main Outcome Measurements
Anterograde SBE procedure time, diagnostic yield, and complications.
Results
Thirty-eight anterograde SBEs were performed. The mean age was 62 (42% female). Patients (97%) were referred for gastrointestinal bleeding, Crohn's disease, suspected polyps or neoplasia, and abnormal capsule endoscopy. The mean procedure time was 49 ± 19 minutes. The estimated depth of insertion: proximal jejunum (34%), mid-jejunum (45%), distal jejunum (21%). The SBE diagnostic yield was 47%, with significant findings in 18 patients. Findings included: angiectasias, bleeding, abnormal mucosa, ulceration, polyps, and foreign body. The therapeutic yield was 42%, with lesion ablation performed in 24%. Diagnostic biopsies were performed in 24% of subjects, and tattooing in 52%. There were no significant complications.
Limitations
Single center retrospective study.
Conclusions
Single balloon enteroscopy appears to be a safe and efficient method for examination of the mid-small bowel. The significant therapeutic yield (42%) suggests comparative studies with double balloon and spiral enteroscopy are warranted.